Universe Pharmaceuticals annual debt-to-equity ratio
2020
2021
2022
2023
2024
2025
Universe Pharmaceuticals Debt-to-Equity Ratio Growth & History (UPC)
Universe Pharmaceuticals's debt-to-equity ratio was 0.16 for fiscal 2025.
View full Universe Pharmaceuticals company overviewUniverse Pharmaceuticals annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | 0.16 | 0.04 | +28.13% |
| 2024 | 2024-09-30 | 0.13 | 0.13 | +65564.92% |
| 2023 | 2023-09-30 | 0.00 | −0.11 | −99.82% |
| 2022 | 2022-09-30 | 0.11 | 0.02 | +20.79% |
| 2021 | 2021-09-30 | 0.09 | −0.03 | −27.48% |
| 2020 | 2020-09-30 | 0.13 | — | — |
Universe Pharmaceuticals quarterly debt-to-equity ratio
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q4.24
Q2.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-03-31 | 0.17 | 0.03 | +22.56% |
| Q4 2025 | 2025-09-30 | 0.16 | 0.04 | +28.13% |
| Q2 2025 | 2025-03-31 | 0.14 | — | — |
| Q4 2024 | 2024-09-30 | 0.13 | 0.13 | +65564.92% |
| Q4 2023 | 2023-09-30 | 0.00 | −0.11 | −99.82% |
| Q2 2023 | 2023-03-31 | 0.09 | 0.01 | +19.98% |
| Q4 2022 | 2022-09-30 | 0.11 | 0.02 | +20.79% |
| Q2 2022 | 2022-03-31 | 0.07 | — | — |
| Q4 2021 | 2021-09-30 | 0.09 | — | — |
Universe Pharmaceuticals debt-to-equity ratio trends
Over the last five fiscal years, Universe Pharmaceuticals's debt-to-equity ratio increased from 0.13 to 0.16, a change of 0.04. The latest reported quarter, Q2 2026, shows 0.17.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Universe Pharmaceuticals source filings ↗